Significant Agreements (Additional Information) (Details) - USD ($) $ in Millions |
Nov. 15, 2024 |
Jun. 30, 2026 |
Dec. 31, 2023 |
Oct. 31, 2023 |
|---|---|---|---|---|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Split Profits and Losses Percentage | 40.00% | |||
| AbbVie Option Agreement [Member] | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Non refundable payment | $ 5.0 | $ 1.0 | ||
| Allowable Expenses Reimbursed Percenage | 60.00% | |||
| Upfront Cash Payment | $ 100.0 | |||
| Milestone payments | $ 100.0 | |||
| Split Profits and Losses Percentage | 60.00% | |||
| Deferred collaboration revenue | $ 6.0 | |||
| Transaction price | $ 6.0 | |||
| AbbVie Option Agreement [Member] | Maximum [Member] | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Milestone payments | $ 300.0 |